In vivo administration of D-arginine: effects on blood pressure and vascular function in angiotensin II-induced hypertensive rats

Atherosclerosis
Gerald WölkartFriedrich Brunner

Abstract

We tested the hypothesis that D-arginine (D-Arg), which is not a substrate for nitric oxide synthase but scavenges reactive oxygen in vitro, is protective in vivo. Rats were made hypertensive by administering angiotensin II (Ang II) (0.7mg kg(-1) per day) for 7 days (Ang II group). Two other groups additionally received either 3 mmol D-Arg (Ang II + D-Arg group) or vitamin C (1g) (Ang II + Vit C group) per day. Sham-operated animals served as controls (n = 6-9). Systolic blood pressure was monitored daily and cardiovascular function determined ex vivo at 7 days. Ang II raised systolic blood pressure to 184mmHg, the increase was slightly attenuated by D-Arg treatment (-17mmHg; P < 0.05 versus Ang II alone) and prevented by Vit C. Acetylcholine-induced coronary relaxation was impaired in the Ang II group (P < 0.05 versus sham), the impairment was no different in the Ang II + D-Arg group, but prevented by Vit C. Likewise, Vit C but not D-Arg ameliorated reperfusion endothelium-dependent relaxation. However, in aortic rings D-Arg slightly improved acetylcholine relaxation (P < 0.05). Oxidative stress load estimated in plasma with thiobarbituric acid reactive substance was higher in the Ang II than the sham group, Vit C abolished th...Continue Reading

References

Jun 30, 1988·Biochemical and Biophysical Research Communications·R M PalmerS Moncada
Jun 1, 1993·Journal of Hypertension·K HishikawaT Saruta
Apr 15, 1996·The Journal of Clinical Investigation·P ClarksonJ E Deanfield
Mar 1, 1996·Diabetes Care·D GiuglianoG Paolisso
May 8, 1997·Biochemical and Biophysical Research Communications·T C WascherW F Graier
Sep 23, 1997·Journal of Molecular and Cellular Cardiology·F Brunner
Jun 28, 2000·Cardiovascular Research·F BrunnerT C Wascher
Feb 28, 2002·British Journal of Pharmacology·K de SaramP J Chowienczyk
Mar 29, 2002·Naunyn-Schmiedeberg's Archives of Pharmacology·Astrid SuessenbacherFriedrich Brunner
Apr 19, 2002·Molecular Pharmacology·Achim LassFriedrich Brunner
Oct 17, 2002·Nitric Oxide : Biology and Chemistry·Huige LiUlrich Förstermann
Dec 17, 2002·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·H TapieroK D Tew

❮ Previous
Next ❯

Citations

May 11, 2012·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Stephan C SchäferLucia Mazzolai
Jun 16, 2005·Current Opinion in Cardiology·Islam Bolad, Patrice Delafontaine

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.